A CRISPR screen employing ∼18,000 sgRNAs which targeted >700 kb regions surrounding the genes NF1, NF2, and CUL3 was developed to search for resistance to BRAF inhibitor in melanoma (Sanjana et al., 2016). Here, BRAF is linked to melanoma.